News -Win Consortium

Home › News

News

WIN-MTB-2024002 – WIN International Molecular Tumor Board: A 52-year-old female with unmeasurable Stage IIIc colon cancer logotype

WIN-MTB-2024002 – WIN International Molecular Tumor Board: A 52-year-old female with unmeasurable Stage IIIc colon cancer

Posted: Friday, October 23, 2026

Case Report WIN-MTB-2024001 – WIN International Molecular Tumor Board: A 55-year-old male with glioblastoma exhibiting amplifications in MDM2 and EGFR logotype

Case Report WIN-MTB-2024001 – WIN International Molecular Tumor Board: A 55-year-old male with glioblastoma exhibiting amplifications in MDM2 and EGFR

Posted: Friday, October 23, 2026

Worldwide Innovative Network Consortium: Building a Common Global Cancer Database logotype

Worldwide Innovative Network Consortium: Building a Common Global Cancer Database

Posted: Friday, August 14, 2026

Case Report: WIN-MTB-2024017 – WIN International Molecular Tumor Board: A 48-year-old female with multiple primary cancers logotype

Case Report: WIN-MTB-2024017 – WIN International Molecular Tumor Board: A 48-year-old female with multiple primary cancers

Posted: Monday, July 27, 2026

SWOG and WIN Join Forces to Advance Precision Oncology logotype

SWOG and WIN Join Forces to Advance Precision Oncology

Posted: Tuesday, December 09, 2025

Oncotarget Editor-in-Chief Wafik S. El-Deiry Chairs 2025 WIN Symposium in Collaboration with APM in Philadelphia logotype

Oncotarget Editor-in-Chief Wafik S. El-Deiry Chairs 2025 WIN Symposium in Collaboration with APM in Philadelphia

Posted: Thursday, October 02, 2025

OncoAID - an open access targeted anti-cancer drugs database logotype

OncoAID - an open access targeted anti-cancer drugs database

Posted: Wednesday, August 13, 2025

WIN Consortium is supporting the activation of the Tempus GEMINI-NSCLC study at member institutions in the USA, Canada, Europe, and the Middle East. logotype

WIN Consortium is supporting the activation of the Tempus GEMINI-NSCLC study at member institutions in the USA, Canada, Europe, and the Middle East.

Posted: Friday, July 04, 2025

Case Report WIN-MTB-2023001 WIN International Molecular Tumor Board A 62-year-old male with metastatic colorectal cancer with 5 prior lines of treatment logotype

Case Report WIN-MTB-2023001 WIN International Molecular Tumor Board A 62-year-old male with metastatic colorectal cancer with 5 prior lines of treatment

Posted: Wednesday, June 18, 2025

Worldwide Innovative Network (WIN) Consortium in Personalized Cancer Medicine: Bringing next-generation precision oncology to patients logotype

Worldwide Innovative Network (WIN) Consortium in Personalized Cancer Medicine: Bringing next-generation precision oncology to patients

Posted: Thursday, March 13, 2025

Cure51 Joins Worldwide Innovative Network (WIN) in Personalized Cancer Medicine Consortium - WIN Consortium logotype

Cure51 Joins Worldwide Innovative Network (WIN) in Personalized Cancer Medicine Consortium - WIN Consortium

Posted: Tuesday, November 12, 2024

Rutgers Cancer Institute and Worldwide Innovative Network (WIN) in personalized cancer medicine consortium have joined forces to advance innovative cancer research logotype

Rutgers Cancer Institute and Worldwide Innovative Network (WIN) in personalized cancer medicine consortium have joined forces to advance innovative cancer research

Posted: Thursday, October 10, 2024

1 2 3 ... 10